p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway
Top Cited Papers
- 29 April 2007
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 39 (6) , 741-749
- https://doi.org/10.1038/ng2033
Abstract
The mitogen-activated protein kinase (MAPK) p38alpha controls inflammatory responses and cell proliferation. Using mice carrying conditional Mapk14 (also known as p38alpha) alleles, we investigated its function in postnatal development and tumorigenesis. When we specifically deleted Mapk14 in the mouse embryo, fetuses developed to term but died shortly after birth, probably owing to lung dysfunction. Fetal hematopoietic cells and embryonic fibroblasts deficient in p38alpha showed increased proliferation resulting from sustained activation of the c-Jun N-terminal kinase (JNK)-c-Jun pathway. Notably, in chemical-induced liver cancer development, mice with liver-specific deletion of Mapk14 showed enhanced hepatocyte proliferation and tumor development that correlated with upregulation of the JNK-c-Jun pathway. Furthermore, inactivation of JNK or c-Jun suppressed the increased proliferation of Mapk14-deficient hepatocytes and tumor cells. These results demonstrate a new mechanism whereby p38alpha negatively regulates cell proliferation by antagonizing the JNK-c-Jun pathway in multiple cell types and in liver cancer development.Keywords
This publication has 43 references indexed in Scilit:
- Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38α in abrogating myoblast proliferationThe EMBO Journal, 2007
- c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activityGenes & Development, 2006
- Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activationProceedings of the National Academy of Sciences, 2006
- Green Fluorescent Protein Tagging of Extracellular Signal-Regulated Kinase and p38 Pathways Reveals Novel Dynamics of Pathway Activation during Primary and Metastatic GrowthCancer Research, 2004
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinomaCancer, 2003
- C–Jun–N–Terminal Kinase Drives Cyclin D1 Expression and Proliferation During Liver RegenerationHepatology, 2003
- Differential effects of JNK1 and JNK2 on signal specific induction of apoptosisOncogene, 2002
- Deficiency of the Stress Kinase P38α Results in Embryonic LethalityThe Journal of Experimental Medicine, 2000
- Inducible Gene Targeting in MiceScience, 1995